HHV-8

Yi Liu1,2,3, Xuejiao Yin1,2,3, Shengnan Ding1,2

  • 1Department of Hematology, The First Affiliated Hospital, College of Medicine, Zhejiang University, 79# Qingchun Road, Hangzhou, Zhejiang, 310003, People's Republic of China.

概括

持续治疗改善了多中心卡斯特曼病 (MCD) 患者的无进展生存率,这些患者的人类疹病毒 (HHV) -8阴性状态. 达到最佳的初始反应是从HHV-8阴性MCD的延长治疗中受益的关键.